Influence of Duraflo II heparin-treated extracorporeal circuits on the systemic inflammatory response in patients having coronary bypass

The Journal of Thoracic and Cardiovascular Surgery

Volumn 110, Issue 6, 1995, Pages 1633-1641

  Weerwind, P W ^a   Maessen, J G ^a   van Tits, L J H ^a   Stad, R K ^a   Fransen, E J ^a   de Jong, D S ^a   Penn, O C K M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HEPARIN; HEPARIN LEO; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; AORTA CLAMPING; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; EXTRACORPOREAL CIRCULATION; FEMALE; HEPARINIZATION; HUMAN; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE ACTIVATION; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

CARDIOPULMONARY BYPASS; COMPARATIVE STUDY; CORONARY ARTERY BYPASS; E-SELECTIN; FEMALE; HEPARIN; HUMAN; INFLAMMATION; INFLAMMATION MEDIATORS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; INTERLEUKIN-8; LEUKOCYTES; MALE; MIDDLE AGE; PROSPECTIVE STUDIES; RECEPTORS, TUMOR NECROSIS FACTOR; SURFACE PROPERTIES; SURGICAL PROCEDURES, ELECTIVE;

EID: 0028856766     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(95)70024-2     Document Type: Article

References (52)

1. Interaction of neutrophil granulocytes and endothelium in vitro
2. Comparative adherence of granulocytes to endothelial monolayers and nylon fibre
3. Leukocyte-endothelial interactions
4. Neutrophil adherence to human endothelial cells
5. White blood cell deformability and plugging of skeletal muscle capillaries in hemorrhagic shock
6. Neutrophil retention in model capillaries. Deformability, geometry and hydrodynamic forces
7. Neutrophil deformability in vitro determines in vivo retention in man
8. The adhesive interaction between polymorphonuclear leukocytes and endothelial cells in vitro
9. Inflammatory mediators stimulate granulocyte adherence to cultured human endothelial cells
10. Leukocyte adhesion to cells in immune and inflammatory responses
11. Abnormalities of polymorphonuclear leukocyte function associated with a heritable deficiency of high molecular weight surface glycoproteins (GP138): common relationship to diminished cell adherence
12. Inherited deficiency of the MAC-1, LFA-1, p150,95 glycoprotein family and its molecular basis
13. Neutrophil adherence to human endothelium in vivo occurs by CDw18 (Mol, MAC-1/LFA-1/GP150,95) glycoprotein-dependent and -independent mechanisms
14. Induction and detection of human endothelial activation antigen in vivo
15. Interleukin-1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes and related leukocyte cell lines
16. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function–associated antigen 1 (LFA-1)
17. Induction by IL-1 and interferongamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1)
18. Primary structure of ICAM-1 demonstrates interaction between members of immunoglobulin and integrin supergene families
19. Identification of an inducible endothelial-leukocyte adhesion molecule
20. Activation of human endothelium by lymphokines: overlapping patterns of antigenic modulation by interleukin-1, tumor necrosis factor, and immune interferon
21. Interleukin-1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage
22. An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin-1, and tumor necrosis factor increases neutrophil adherence by CDw18-dependent mechanisms
23. Heparin bonding on colloidal graphite surfaces
24. Heparinized polyurethanes: in vitro and in vivo studies
25. Reduced blood loss and transfusion requirements with low systemic heparinization: preliminary clinical results in coronary artery revascularization
26. Heparin coating of extracorporeal circuits reduces thrombin formation in patients undergoing cardiopulmonary bypass
27. Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b
28. Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertase
29. E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro
30. Slow release of soluble TNF-receptors by monocytes in vitro
31. Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-α, interleukin-6 and interleukin-8 release by human monocytes and alveolar macrophages
32. Differential regulatory effects of adenosine on cytokine release by activated human monocytes
33. Heparin-induced thrombocytopenia: mechanism of interaction of the heparin-dependent antibody with platelets
34. Thrombin inactivation on surfaces with covalently bonded heparin
35. Bleeding complications associated with cardiopulmonary bypass
36. Heparin-coated equipment reduces complement activation during cardiopulmonary bypass in the pig
37. Reduced granulocyte activation with a heparin-coated device in an in vitro model of cardiopulmonary bypass
38. Heparin coating of an extracorporeal circuit partly improves hemostasis after cardiopulmonary bypass
39. Clinical evaluation of Duraflo II heparin-treated extracorporeal circuits on the activation of the kinin and coagulation system
40. Surface treatments for perfusion devices
41. Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass
42. Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of IL8 and IL6 in reperfusion injury
43. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-α, LPS and IL-1ß
44. Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans
45. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor-alfa in vitro and in vivo
46. Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinaemia
47. Increased plasma levels of soluble tumor necrosis factor receptors in sepsis syndrome: correlation with plasma creatinine
48. Interleukin-6: an overview
49. Froon AHM, Greve JW, Buurman WA. Abdominal aortic aneurysm repair: inflammatory parameters and clinical outcome. Eur J Surg [In press].
50. Circulating adhesion molecules in disease
51. Heparin-coated bypass circuits reduce pulmonary injury